|
Market Closed -
Australian S.E.
01:10:10 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.0230 AUD | 0.00% |
|
-11.54% | -94.46% |
| 09-16 | Immutep refocuses efti development on head and neck cancer and soft tissue sarcoma | FI |
| 09-15 | Immutep's Drug Candidate Now Has Clearer Potential Development Path, Jefferies Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 23.58M | - | - | |||
| 65B | |||||
| 51.2B | |||||
| 51.19B | |||||
| 43.93B | |||||
| 41.96B |
- Stock Market
- Stocks
- IMM Stock
- Charts Immutep Limited
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
